Abstract: This invention relates to a composition comprising oligoproanthocyanidins (OPC) and omega-3 fatty acids, for use in preventing or stabilizing the development and/or the progression of a diabetes-related eye condition in a subject; this invention includes a functional food, a nutraceutical composition or a food or dietary supplement comprising said composition; this invention also relates to a pharmaceutical composition or a veterinarian product comprising oligoproanthocyanidins (OPC) and omega-3 fatty acids.
Type:
Application
Filed:
January 13, 2012
Publication date:
November 7, 2013
Applicant:
VISIOTACT PHARMA
Inventors:
Reda Hadj-Slimane, Yves Lepelletier, Tewfik Hadj-Slimane
Abstract: The invention relates to a composition comprising an enzyme selected from the group comprising superoxide dismutase (SOD) and SOD mimics and the like, in association with lutein and at least one stereoisomer of zeaxanthin; the invention also includes a kit of parts comprising such composition, wherein the kit comprises a first part comprising the enzyme, and a second part comprising lutein and at least one zeaxanthin isomer; according to the invention, the composition or the kit of part may be included in a functional food, a nutraceutical composition or a food or dietary supplement, a medicament or a pharmaceutical composition, or a veterinarian product; the invention also relates to a composition for use in treating, preventing or stabilizing a disease, condition or disorder of the eye associated to oxidative stress, comprising administering to a subject in need thereof a medicament or a pharmaceutical composition according to the invention.
Type:
Application
Filed:
September 22, 2011
Publication date:
August 1, 2013
Applicant:
VISIOTACT PHARMA
Inventors:
Yves Lepelletier, Reda Hadj-Slimane, Tewfik Hadj-Slimane